Aptevo Therapeutics Inc. (APVO) › Shareholders' EquityAptevo Therapeutics Inc. (APVO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2014: $94.61M2015: $88.62M2016: $50.57M2017: $82.03M2018: $30.41M2019: $11.84M2020: $16.59M2021: $1.22M2022: $17.97M2023: $12.22M2024: $4.75M2025: $17.38M$17.38M2014Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$17.38M+265.5%2024$4.75M-61.1%2023$12.22M-32.0%2022$17.97M+1378.1%2021$1.22M-92.7%2020$16.59M+40.1%2019$11.84M-61.1%2018$30.41M-62.9%2017$82.03M+62.2%2016$50.57M-42.9%2015$88.62M-6.3%2014$94.61M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share